
|Articles|July 23, 2020
Episode 61: Preparing for Virtual High-Stakes Meetings
Author(s)Elaine Quilici
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
Advertisement
Jim and Cindy DiBiasi, co-founders of 3D Communications, discuss how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Pharmaceutical Executive Magazine
·
Episode 61: Preparing for Virtual High-Stakes Meetings
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly to Deny 340B Drug Pricing Due to Claims-Data Policy: Report
2
What’s Trending in Oncology? A Discussion Following ASCO 2026 with Anne Marie Robertson from EVERSANA
3
New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge
4
Ascidian and Eli Lilly Enter $1.9 Billion Global Research Collaboration to Develop RNA Exon Editors
5

